BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

765 related articles for article (PubMed ID: 30180906)

  • 1. PHF8 upregulation contributes to autophagic degradation of E-cadherin, epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma.
    Zhou W; Gong L; Wu Q; Xing C; Wei B; Chen T; Zhou Y; Yin S; Jiang B; Xie H; Zhou L; Zheng S
    J Exp Clin Cancer Res; 2018 Sep; 37(1):215. PubMed ID: 30180906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirtuin6 (SIRT6) Promotes the EMT of Hepatocellular Carcinoma by Stimulating Autophagic Degradation of E-Cadherin.
    Han LL; Jia L; Wu F; Huang C
    Mol Cancer Res; 2019 Nov; 17(11):2267-2280. PubMed ID: 31551254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
    Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
    Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma.
    Xia L; Huang W; Tian D; Zhu H; Qi X; Chen Z; Zhang Y; Hu H; Fan D; Nie Y; Wu K
    Hepatology; 2013 Feb; 57(2):610-24. PubMed ID: 22911555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA NRON is downregulated in HCC and suppresses tumour cell proliferation and metastasis.
    Yao Z; Xiong Z; Li R; Liang H; Jia C; Deng M
    Biomed Pharmacother; 2018 Aug; 104():102-109. PubMed ID: 29772429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinoma.
    Liu TA; Jan YJ; Ko BS; Liang SM; Chen SC; Wang J; Hsu C; Wu YM; Liou JY
    PLoS One; 2013; 8(3):e57968. PubMed ID: 23483955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type IIA topoisomerase (TOP2A) triggers epithelial-mesenchymal transition and facilitates HCC progression by regulating Snail expression.
    Dong Y; Sun X; Zhang K; He X; Zhang Q; Song H; Xu M; Lu H; Ren R
    Bioengineered; 2021 Dec; 12(2):12967-12979. PubMed ID: 34939898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNAI1 Promotes the Cholangiocellular Phenotype, but not Epithelial-Mesenchymal Transition, in a Murine Hepatocellular Carcinoma Model.
    Xu M; Wang J; Xu Z; Li R; Wang P; Shang R; Cigliano A; Ribback S; Solinas A; Pes GM; Evert K; Wang H; Song X; Zhang S; Che L; Pascale RM; Calvisi DF; Liu Q; Chen X
    Cancer Res; 2019 Nov; 79(21):5563-5574. PubMed ID: 31383647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA TRERNA1 facilitates hepatocellular carcinoma metastasis by dimethylating H3K9 in the CDH1 promoter region via the recruitment of the EHMT2/SNAI1 complex.
    Song W; Gu Y; Lu S; Wu H; Cheng Z; Hu J; Qian Y; Zheng Y; Fan H
    Cell Prolif; 2019 Jul; 52(4):e12621. PubMed ID: 31012192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM66 promotes malignant progression of hepatocellular carcinoma by inhibiting E-cadherin expression through the EMT pathway.
    Zhang HG; Pan YW; Feng J; Zeng CT; Zhao XQ; Liang B; Zhang WW
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2003-2012. PubMed ID: 30915743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN.
    Zhang QY; Men CJ; Ding XW
    J Cell Biochem; 2019 Sep; 120(9):14885-14898. PubMed ID: 31044454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-122 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma by targeting Snail1 and Snail2 and suppressing WNT/β-cadherin signaling pathway.
    Jin Y; Wang J; Han J; Luo D; Sun Z
    Exp Cell Res; 2017 Nov; 360(2):210-217. PubMed ID: 28890291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition.
    Xu J; Zhang X; Wang H; Ge S; Gao T; Song L; Wang X; Li H; Qin Y; Zhang Z
    Biomed Pharmacother; 2017 Apr; 88():421-429. PubMed ID: 28122307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor -1α in hepatocellular carcinoma.
    Zhang L; Huang G; Li X; Zhang Y; Jiang Y; Shen J; Liu J; Wang Q; Zhu J; Feng X; Dong J; Qian C
    BMC Cancer; 2013 Mar; 13():108. PubMed ID: 23496980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metastasin leads to poor prognosis of hepatocellular carcinoma through partly inducing EMT.
    Zheng X; Gai X; Wu Z; Liu Q; Yao Y
    Oncol Rep; 2013 May; 29(5):1811-8. PubMed ID: 23483190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
    Zhou M; Zhang XY; Yu X
    Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA metastasis-associated lung adenocarcinoma transcript 1 cooperates with enhancer of zeste homolog 2 to promote hepatocellular carcinoma development by modulating the microRNA-22/Snail family transcriptional repressor 1 axis.
    Chen S; Wang G; Tao K; Cai K; Wu K; Ye L; Bai J; Yin Y; Wang J; Shuai X; Gao J; Pu J; Li H
    Cancer Sci; 2020 May; 111(5):1582-1595. PubMed ID: 32129914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TAZ regulates cell proliferation and epithelial-mesenchymal transition of human hepatocellular carcinoma.
    Xiao H; Jiang N; Zhou B; Liu Q; Du C
    Cancer Sci; 2015 Feb; 106(2):151-9. PubMed ID: 25495189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-383 inhibits proliferation, migration, and invasion in hepatocellular carcinoma cells by targeting PHF8.
    Cheng Y; Liu N; Yang C; Jiang J; Zhao J; Zhao G; Chen F; Zhao H; Li Y
    Mol Genet Genomic Med; 2020 Aug; 8(8):e1272. PubMed ID: 32441881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.